Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Dec 1;368(Pt 2):377–396. doi: 10.1042/BJ20021234

Transglutaminases: nature's biological glues.

Martin Griffin 1, Rita Casadio 1, Carlo M Bergamini 1
PMCID: PMC1223021  PMID: 12366374

Abstract

Transglutaminases (Tgases) are a widely distributed group of enzymes that catalyse the post-translational modification of proteins by the formation of isopeptide bonds. This occurs either through protein cross-linking via epsilon-(gamma-glutamyl)lysine bonds or through incorporation of primary amines at selected peptide-bound glutamine residues. The cross-linked products, often of high molecular mass, are highly resistant to mechanical challenge and proteolytic degradation, and their accumulation is found in a number of tissues and processes where such properties are important, including skin, hair, blood clotting and wound healing. However, deregulation of enzyme activity generally associated with major disruptions in cellular homoeostatic mechanisms has resulted in these enzymes contributing to a number of human diseases, including chronic neurodegeneration, neoplastic diseases, autoimmune diseases, diseases involving progressive tissue fibrosis and diseases related to the epidermis of the skin. In the present review we detail the structural and regulatory features important in mammalian Tgases, with particular focus on the ubiquitous type 2 tissue enzyme. Physiological roles and substrates are discussed with a view to increasing and understanding the pathogenesis of the diseases associated with transglutaminases. Moreover the ability of these enzymes to modify proteins and act as biological glues has not gone unnoticed by the commercial sector. As a consequence, we have included some of the present and future biotechnological applications of this increasingly important group of enzymes.

Full Text

The Full Text of this article is available as a PDF (677.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aboumahmoud R., Savello P. Crosslinking of whey protein by transglutaminase. J Dairy Sci. 1990 Feb;73(2):256–263. doi: 10.3168/jds.S0022-0302(90)78668-7. [DOI] [PubMed] [Google Scholar]
  2. Achyuthan K. E., Goodell R. J., Kennedye J. R., Lee K. N., Henley A., Stiefer J. R., Birckbichler P. J. Immunochemical analyses of human plasma fibronectin-cytosolic transglutaminase interactions. J Immunol Methods. 1995 Mar 13;180(1):69–79. doi: 10.1016/0022-1759(94)00300-l. [DOI] [PubMed] [Google Scholar]
  3. Achyuthan K. E., Greenberg C. S. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem. 1987 Feb 5;262(4):1901–1906. [PubMed] [Google Scholar]
  4. Aeschlimann D., Kaupp O., Paulsson M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. J Cell Biol. 1995 May;129(3):881–892. doi: 10.1083/jcb.129.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Aeschlimann D., Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res. 2000;41(1):1–27. doi: 10.3109/03008200009005638. [DOI] [PubMed] [Google Scholar]
  6. Akimov S. S., Belkin A. M. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood. 2001 Sep 1;98(5):1567–1576. doi: 10.1182/blood.v98.5.1567. [DOI] [PubMed] [Google Scholar]
  7. Akimov S. S., Belkin A. M. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition. J Cell Sci. 2001 Aug;114(Pt 16):2989–3000. doi: 10.1242/jcs.114.16.2989. [DOI] [PubMed] [Google Scholar]
  8. Akimov S. S., Krylov D., Fleischman L. F., Belkin A. M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol. 2000 Feb 21;148(4):825–838. doi: 10.1083/jcb.148.4.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ambrus A., Bányai I., Weiss M. S., Hilgenfeld R., Keresztessy Z., Muszbek L., Fésüs L. Calcium binding of transglutaminases: a 43Ca NMR study combined with surface polarity analysis. J Biomol Struct Dyn. 2001 Aug;19(1):59–74. doi: 10.1080/07391102.2001.10506720. [DOI] [PubMed] [Google Scholar]
  10. Amendola A., Gougeon M. L., Poccia F., Bondurand A., Fesus L., Piacentini M. Induction of "tissue" transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11057–11062. doi: 10.1073/pnas.93.20.11057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Antonyak M. A., Singh U. S., Lee D. A., Boehm J. E., Combs C., Zgola M. M., Page R. L., Cerione R. A. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem. 2001 Jul 3;276(36):33582–33587. doi: 10.1074/jbc.M105318200. [DOI] [PubMed] [Google Scholar]
  12. Antonyak Marc A., Boehm Jason E., Cerione Richard A. Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase. J Biol Chem. 2002 Feb 19;277(17):14712–14716. doi: 10.1074/jbc.M112259200. [DOI] [PubMed] [Google Scholar]
  13. Aoudjit F., Vuori K. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J Cell Biol. 2001 Feb 5;152(3):633–643. doi: 10.1083/jcb.152.3.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Arentz-Hansen H., Körner R., Molberg O., Quarsten H., Vader W., Kooy Y. M., Lundin K. E., Koning F., Roepstorff P., Sollid L. M. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 2000 Feb 21;191(4):603–612. doi: 10.1084/jem.191.4.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Balklava Zita, Verderio Elisabetta, Collighan Russell, Gross Stephane, Adams Julian, Griffin Martin. Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem. 2002 Feb 26;277(19):16567–16575. doi: 10.1074/jbc.M109836200. [DOI] [PubMed] [Google Scholar]
  16. Ballestar E., Franco L. Use of the transglutaminase reaction to study the dissociation of histone N-terminal tails from DNA in nucleosome core particles. Biochemistry. 1997 May 20;36(20):5963–5969. doi: 10.1021/bi9626620. [DOI] [PubMed] [Google Scholar]
  17. Barnes R. N., Bungay P. J., Elliott B. M., Walton P. L., Griffin M. Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis. Carcinogenesis. 1985 Mar;6(3):459–463. doi: 10.1093/carcin/6.3.459. [DOI] [PubMed] [Google Scholar]
  18. Baskakov I., Bolen D. W. Forcing thermodynamically unfolded proteins to fold. J Biol Chem. 1998 Feb 27;273(9):4831–4834. doi: 10.1074/jbc.273.9.4831. [DOI] [PubMed] [Google Scholar]
  19. Belkin A. M., Akimov S. S., Zaritskaya L. S., Ratnikov B. I., Deryugina E. I., Strongin A. Y. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem. 2001 Mar 2;276(21):18415–18422. doi: 10.1074/jbc.M010135200. [DOI] [PubMed] [Google Scholar]
  20. Benedetti L., Grignani F., Scicchitano B. M., Jetten A. M., Diverio D., Lo Coco F., Avvisati G., Gambacorti-Passerini C., Adamo S., Levin A. A. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase. Blood. 1996 Mar 1;87(5):1939–1950. [PubMed] [Google Scholar]
  21. Beninati S., Mukherjee A. B. A novel transglutaminase-catalyzed posttranslational modification of HIV-1 aspartyl protease. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1211–1218. doi: 10.1016/0006-291x(92)90432-k. [DOI] [PubMed] [Google Scholar]
  22. Bergamini C. M., Dean M., Matteucci G., Hanau S., Tanfani F., Ferrari C., Boggian M., Scatturin A. Conformational stability of human erythrocyte transglutaminase. Patterns of thermal unfolding at acid and alkaline pH. Eur J Biochem. 1999 Dec;266(2):575–582. doi: 10.1046/j.1432-1327.1999.00900.x. [DOI] [PubMed] [Google Scholar]
  23. Bergamini C. M. GTP modulates calcium binding and cation-induced conformational changes in erythrocyte transglutaminase. FEBS Lett. 1988 Nov 7;239(2):255–258. doi: 10.1016/0014-5793(88)80928-1. [DOI] [PubMed] [Google Scholar]
  24. Bergamini C. M., Signorini M., Barbato R., Menabò R., Di Lisa F., Gorza L., Beninati S. Transglutaminase-catalyzed polymerization of troponin in vitro. Biochem Biophys Res Commun. 1995 Jan 5;206(1):201–206. doi: 10.1006/bbrc.1995.1028. [DOI] [PubMed] [Google Scholar]
  25. Bergamini C. M., Signorini M. Calcium dependent reversible inactivation of erythrocyte transglutaminase by acrylamide. Biochem Int. 1988 Nov;17(5):855–862. [PubMed] [Google Scholar]
  26. Bergamini C. M., Signorini M., Caselli L., Melandri P. Regulation of transglutaminase activity by GTP in digitonin permeabilized Yoshida tumor cells. Biochem Mol Biol Int. 1993 Jul;30(4):727–732. [PubMed] [Google Scholar]
  27. Bergamini C. M., Signorini M. In vivo inactivation of transglutaminase during the acute acrylamide toxic syndrome in the rat. Experientia. 1990 Mar 15;46(3):278–281. doi: 10.1007/BF01951765. [DOI] [PubMed] [Google Scholar]
  28. Bershad S. Developments in topical retinoid therapy for acne. Semin Cutan Med Surg. 2001 Sep;20(3):154–161. doi: 10.1053/sder.2001.27555. [DOI] [PubMed] [Google Scholar]
  29. Birckbichler P. J., Bonner R. B., Hurst R. E., Bane B. L., Pitha J. V., Hemstreet G. P., 3rd Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma. Cancer. 2000 Jul 15;89(2):412–423. doi: 10.1002/1097-0142(20000715)89:2<412::aid-cncr29>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  30. Birckbichler P. J., Orr G. R., Conway E., Patterson M. K., Jr Transglutaminase activity in normal and transformed cells. Cancer Res. 1977 May;37(5):1340–1344. [PubMed] [Google Scholar]
  31. Birckbichler P. J., Orr G. R., Patterson M. K., Jr, Conway E., Carter H. A. Increase in proliferative markers after inhibition of transglutaminase. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5005–5008. doi: 10.1073/pnas.78.8.5005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Birckbichler P. J., Patterson M. K., Jr Cellular transglutaminase, growth, and transformation. Ann N Y Acad Sci. 1978 Jun 20;312:354–365. doi: 10.1111/j.1749-6632.1978.tb16813.x. [DOI] [PubMed] [Google Scholar]
  33. Birckbichler P. J., Upchurch H. F., Patterson M. K., Jr, Conway E. A monoclonal antibody to cellular transglutaminase. Hybridoma. 1985 Summer;4(2):179–186. doi: 10.1089/hyb.1985.4.179. [DOI] [PubMed] [Google Scholar]
  34. Bungay P. J., Potter J. M., Griffin M. The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism. Biochem J. 1984 May 1;219(3):819–827. doi: 10.1042/bj2190819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Burgoyne R. D., Weiss J. L. The neuronal calcium sensor family of Ca2+-binding proteins. Biochem J. 2001 Jan 1;353(Pt 1):1–12. [PMC free article] [PubMed] [Google Scholar]
  36. Butler S. J., Landon M. Transglutaminase-catalysed incorporation of putrescine into denatured cytochrome. Preparation of a mono-substituted derivative reactive with cytochrome c oxidase. Biochim Biophys Acta. 1981 Sep 29;670(2):214–221. doi: 10.1016/0005-2795(81)90012-x. [DOI] [PubMed] [Google Scholar]
  37. Candi E., Melino G., Lahm A., Ceci R., Rossi A., Kim I. G., Ciani B., Steinert P. M. Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing. J Biol Chem. 1998 May 29;273(22):13693–13702. doi: 10.1074/jbc.273.22.13693. [DOI] [PubMed] [Google Scholar]
  38. Candi E., Oddi S., Terrinoni A., Paradisi A., Ranalli M., Finazzi-Agró A., Melino G. Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro. J Biol Chem. 2001 Jul 6;276(37):35014–35023. doi: 10.1074/jbc.M010157200. [DOI] [PubMed] [Google Scholar]
  39. Casadio R., Polverini E., Mariani P., Spinozzi F., Carsughi F., Fontana A., Polverino de Laureto P., Matteucci G., Bergamini C. M. The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem. 1999 Jun;262(3):672–679. doi: 10.1046/j.1432-1327.1999.00437.x. [DOI] [PubMed] [Google Scholar]
  40. Catani M. V., Bernassola F., Rossi A., Melino G. Inhibition of clotting factor XIII activity by nitric oxide. Biochem Biophys Res Commun. 1998 Aug 10;249(1):275–278. doi: 10.1006/bbrc.1998.9130. [DOI] [PubMed] [Google Scholar]
  41. Chakravarty R., Rice R. H. Acylation of keratinocyte transglutaminase by palmitic and myristic acids in the membrane Anchorage region. J Biol Chem. 1989 Jan 5;264(1):625–629. [PubMed] [Google Scholar]
  42. Chang S. K., Chung S. I. Cellular transglutaminase. The particulate-associated transglutaminase from chondrosarcoma and liver: partial purification and characterization. J Biol Chem. 1986 Jun 25;261(18):8112–8121. [PubMed] [Google Scholar]
  43. Chen J. S., Mehta K. Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol. 1999 Aug;31(8):817–836. doi: 10.1016/s1357-2725(99)00045-x. [DOI] [PubMed] [Google Scholar]
  44. Chen S., Berthelier V., Yang W., Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J Mol Biol. 2001 Aug 3;311(1):173–182. doi: 10.1006/jmbi.2001.4850. [DOI] [PubMed] [Google Scholar]
  45. Chiantore M. V., Giandomenico V., De Luca L. M. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: correlation with tissue transglutaminase. Biochem Biophys Res Commun. 1999 Jan 27;254(3):636–641. doi: 10.1006/bbrc.1998.9987. [DOI] [PubMed] [Google Scholar]
  46. Chung S. I., Lewis M. S., Folk J. E. Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. J Biol Chem. 1974 Feb 10;249(3):940–950. [PubMed] [Google Scholar]
  47. Citron B. A., SantaCruz K. S., Davies P. J., Festoff B. W. Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease. J Biol Chem. 2000 Sep 29;276(5):3295–3301. doi: 10.1074/jbc.M004776200. [DOI] [PubMed] [Google Scholar]
  48. Cohen I., Anderson B. Immunochemical characterization of the transglutaminase-catalyzed polymer of activated platelets. Thromb Res. 1987 Aug 15;47(4):409–416. doi: 10.1016/0049-3848(87)90456-7. [DOI] [PubMed] [Google Scholar]
  49. Cooper A. J., Sheu K. F., Burke J. R., Strittmatter W. J., Gentile V., Peluso G., Blass J. P. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability. J Neurochem. 1999 Mar;72(3):889–899. doi: 10.1046/j.1471-4159.1999.0720889.x. [DOI] [PubMed] [Google Scholar]
  50. Cooper A. J., Sheu K. R., Burke J. R., Onodera O., Strittmatter W. J., Roses A. D., Blass J. P. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12604–12609. doi: 10.1073/pnas.94.23.12604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Cooper A. J., Sheu K. R., Burke J. R., Onodera O., Strittmatter W. J., Roses A. D., Blass J. P. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12604–12609. doi: 10.1073/pnas.94.23.12604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Cordella-Miele E., Miele L., Mukherjee A. B. A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity. J Biol Chem. 1990 Oct 5;265(28):17180–17188. [PubMed] [Google Scholar]
  53. Coussons P. J., Price N. C., Kelly S. M., Smith B., Sawyer L. Factors that govern the specificity of transglutaminase-catalysed modification of proteins and peptides. Biochem J. 1992 Mar 15;282(Pt 3):929–930. doi: 10.1042/bj2820929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. D'Argenio G., Grossman A., Cosenza V., Valle N. D., Mazzacca G., Bishop P. D. Recombinant factor XIII improves established experimental colitis in rats. Dig Dis Sci. 2000 May;45(5):987–997. doi: 10.1023/a:1005541512152. [DOI] [PubMed] [Google Scholar]
  55. Davies P. J., Murtaugh M. P., Moore W. T., Jr, Johnson G. S., Lucas D. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. J Biol Chem. 1985 Apr 25;260(8):5166–5174. [PubMed] [Google Scholar]
  56. De Laurenzi V., Melino G. Gene disruption of tissue transglutaminase. Mol Cell Biol. 2001 Jan;21(1):148–155. doi: 10.1128/MCB.21.1.148-155.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Del Duca S., Beninati S., Serafini-Fracassini D. Polyamines in chloroplasts: identification of their glutamyl and acetyl derivatives. Biochem J. 1995 Jan 1;305(Pt 1):233–237. doi: 10.1042/bj3050233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Dhar A., Liu S., Klucik J., Berlin K. D., Madler M. M., Lu S., Ivey R. T., Zacheis D., Brown C. W., Nelson E. C. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids. J Med Chem. 1999 Sep 9;42(18):3602–3614. doi: 10.1021/jm9900974. [DOI] [PubMed] [Google Scholar]
  59. Di Venere A., Rossi A., De Matteis F., Rosato N., Agrò A. F., Mei G. Opposite effects of Ca(2+) and GTP binding on tissue transglutaminase tertiary structure. J Biol Chem. 2000 Feb 11;275(6):3915–3921. doi: 10.1074/jbc.275.6.3915. [DOI] [PubMed] [Google Scholar]
  60. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E. O., Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997 Jul;3(7):797–801. doi: 10.1038/nm0797-797. [DOI] [PubMed] [Google Scholar]
  61. Dubbink H. J., de Waal L., van Haperen R., Verkaik N. S., Trapman J., Romijn J. C. The human prostate-specific transglutaminase gene (TGM4): genomic organization, tissue-specific expression, and promoter characterization. Genomics. 1998 Aug 1;51(3):434–444. doi: 10.1006/geno.1998.5393. [DOI] [PubMed] [Google Scholar]
  62. Eckert R. L., Welter J. F. Transcription factor regulation of epidermal keratinocyte gene expression. Mol Biol Rep. 1996;23(1):59–70. doi: 10.1007/BF00357073. [DOI] [PubMed] [Google Scholar]
  63. Eligula L., Chuang L., Phillips M. L., Motoki M., Seguro K., Muhlrad A. Transglutaminase-induced cross-linking between subdomain 2 of G-actin and the 636-642 lysine-rich loop of myosin subfragment 1. Biophys J. 1998 Feb;74(2 Pt 1):953–963. doi: 10.1016/S0006-3495(98)74018-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Fabbi M., Marimpietri D., Martini S., Brancolini C., Amoresano A., Scaloni A., Bargellesi A., Cosulich E. Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation. Cell Death Differ. 1999 Oct;6(10):992–1001. doi: 10.1038/sj.cdd.4400573. [DOI] [PubMed] [Google Scholar]
  65. Feng J. F., Readon M., Yadav S. P., Im M. J. Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry. 1999 Aug 17;38(33):10743–10749. doi: 10.1021/bi9905009. [DOI] [PubMed] [Google Scholar]
  66. Fesus L., Madi A., Balajthy Z., Nemes Z., Szondy Z. Transglutaminase induction by various cell death and apoptosis pathways. Experientia. 1996 Oct 31;52(10-11):942–949. doi: 10.1007/BF01920102. [DOI] [PubMed] [Google Scholar]
  67. Fesus L., Metsis M. L., Muszbek L., Koteliansky V. E. Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments. Eur J Biochem. 1986 Jan 15;154(2):371–374. doi: 10.1111/j.1432-1033.1986.tb09407.x. [DOI] [PubMed] [Google Scholar]
  68. Fesus L., Thomazy V., Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 1987 Nov 16;224(1):104–108. doi: 10.1016/0014-5793(87)80430-1. [DOI] [PubMed] [Google Scholar]
  69. Folk J. E., Finlayson J. S. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem. 1977;31:1–133. doi: 10.1016/s0065-3233(08)60217-x. [DOI] [PubMed] [Google Scholar]
  70. Folk J. E., Park M. H., Chung S. I., Schrode J., Lester E. P., Cooper H. L. Polyamines as physiological substrates for transglutaminases. J Biol Chem. 1980 Apr 25;255(8):3695–3700. [PubMed] [Google Scholar]
  71. Fox B. A., Yee V. C., Pedersen L. C., Le Trong I., Bishop P. D., Stenkamp R. E., Teller D. C. Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by x-ray crystallography. J Biol Chem. 1999 Feb 19;274(8):4917–4923. doi: 10.1074/jbc.274.8.4917. [DOI] [PubMed] [Google Scholar]
  72. Fromm J. R., Hileman R. E., Caldwell E. E., Weiler J. M., Linhardt R. J. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch Biochem Biophys. 1995 Nov 10;323(2):279–287. doi: 10.1006/abbi.1995.9963. [DOI] [PubMed] [Google Scholar]
  73. Fujimoto M., Kanzaki H., Nakayama H., Higuchi T., Hatayama H., Iwai M., Kaneko Y., Mori T., Fujita J. Requirement for transglutaminase in progesterone-induced decidualization of human endometrial stromal cells. Endocrinology. 1996 Mar;137(3):1096–1101. doi: 10.1210/endo.137.3.8603579. [DOI] [PubMed] [Google Scholar]
  74. Fésüs L., Horváth A., Hársfalvi J. Interaction between tissue transglutaminase and phospholipid vesicles. FEBS Lett. 1983 May 2;155(1):1–5. doi: 10.1016/0014-5793(83)80196-3. [DOI] [PubMed] [Google Scholar]
  75. Fésüs L., Laki K. Two antigenic sites of tissue transglutaminase. Biochemistry. 1977 Sep 6;16(18):4061–4066. doi: 10.1021/bi00637a019. [DOI] [PubMed] [Google Scholar]
  76. Gaudry C. A., Verderio E., Aeschlimann D., Cox A., Smith C., Griffin M. Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem. 1999 Oct 22;274(43):30707–30714. doi: 10.1074/jbc.274.43.30707. [DOI] [PubMed] [Google Scholar]
  77. Gaudry C. A., Verderio E., Jones R. A., Smith C., Griffin M. Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Exp Cell Res. 1999 Oct 10;252(1):104–113. doi: 10.1006/excr.1999.4633. [DOI] [PubMed] [Google Scholar]
  78. Gentile V., Davies P. J., Baldini A. The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization. Genomics. 1994 Mar 15;20(2):295–297. doi: 10.1006/geno.1994.1170. [DOI] [PubMed] [Google Scholar]
  79. Gentile V., Sepe C., Calvani M., Melone M. A., Cotrufo R., Cooper A. J., Blass J. P., Peluso G. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch Biochem Biophys. 1998 Apr 15;352(2):314–321. doi: 10.1006/abbi.1998.0592. [DOI] [PubMed] [Google Scholar]
  80. Gentile V., Thomazy V., Piacentini M., Fesus L., Davies P. J. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J Cell Biol. 1992 Oct;119(2):463–474. doi: 10.1083/jcb.119.2.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Gerber U., Jucknischke U., Putzien S., Fuchsbauer H. L. A rapid and simple method for the purification of transglutaminase from Streptoverticillium mobaraense. Biochem J. 1994 May 1;299(Pt 3):825–829. doi: 10.1042/bj2990825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Gootenberg J. E. Factor concentrates for the treatment of factor XIII deficiency. Curr Opin Hematol. 1998 Nov;5(6):372–375. doi: 10.1097/00062752-199811000-00003. [DOI] [PubMed] [Google Scholar]
  83. Greenberg C. S., Birckbichler P. J., Rice R. H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991 Dec;5(15):3071–3077. doi: 10.1096/fasebj.5.15.1683845. [DOI] [PubMed] [Google Scholar]
  84. Grenard P., Bates M. K., Aeschlimann D. Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z. J Biol Chem. 2001 Jun 4;276(35):33066–33078. doi: 10.1074/jbc.M102553200. [DOI] [PubMed] [Google Scholar]
  85. Grenard P., Bresson-Hadni S., El Alaoui S., Chevallier M., Vuitton D. A., Ricard-Blum S. Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J Hepatol. 2001 Sep;35(3):367–375. doi: 10.1016/s0168-8278(01)00135-0. [DOI] [PubMed] [Google Scholar]
  86. Griffin M., Smith L. L., Wynne J. Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol. 1979 Dec;60(6):653–661. [PMC free article] [PubMed] [Google Scholar]
  87. Griffin M., Verderio E. Tissue transglutaminase in cell death. Symp Soc Exp Biol. 2000;52:223–240. [PubMed] [Google Scholar]
  88. Groenen P. J., Bloemendal H., de Jong W. W. The carboxy-terminal lysine of alpha B-crystallin is an amine-donor substrate for tissue transglutaminase. Eur J Biochem. 1992 Apr 15;205(2):671–674. doi: 10.1111/j.1432-1033.1992.tb16827.x. [DOI] [PubMed] [Google Scholar]
  89. Grossmann J., Walther K., Artinger M., Kiessling S., Schölmerich J. Apoptotic signaling during initiation of detachment-induced apoptosis ("anoikis") of primary human intestinal epithelial cells. Cell Growth Differ. 2001 Mar;12(3):147–155. [PubMed] [Google Scholar]
  90. Halttunen T., Mäki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology. 1999 Mar;116(3):566–572. doi: 10.1016/s0016-5085(99)70178-2. [DOI] [PubMed] [Google Scholar]
  91. Hand D., Bungay P. J., Elliott B. M., Griffin M. Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein. Biosci Rep. 1985 Dec;5(12):1079–1086. doi: 10.1007/BF01119629. [DOI] [PubMed] [Google Scholar]
  92. Hand D., Dias D., Haynes L. W. Stabilization of collagen-tailed acetylcholinesterase in muscle cells through extracellular anchorage by transglutaminase-catalyzed cross-linking. Mol Cell Biochem. 2000 Jan;204(1-2):65–76. doi: 10.1023/a:1007068017315. [DOI] [PubMed] [Google Scholar]
  93. Hand D., Elliott B. M., Griffin M. Characterisation of the cellular substrates for transglutaminase in normal liver and hepatocellular carcinoma. Biochim Biophys Acta. 1990 Jan 29;1033(1):57–64. doi: 10.1016/0304-4165(90)90194-2. [DOI] [PubMed] [Google Scholar]
  94. Hand D., Elliott B. M., Griffin M. Characterisation of the cellular substrates for transglutaminase in normal liver and hepatocellular carcinoma. Biochim Biophys Acta. 1990 Jan 29;1033(1):57–64. doi: 10.1016/0304-4165(90)90194-2. [DOI] [PubMed] [Google Scholar]
  95. Hand D., Elliott B. M., Griffin M. Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis. Biochim Biophys Acta. 1988 Jun 30;970(2):137–145. doi: 10.1016/0167-4889(88)90172-3. [DOI] [PubMed] [Google Scholar]
  96. Haroon Z. A., Hettasch J. M., Lai T. S., Dewhirst M. W., Greenberg C. S. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 1999 Oct;13(13):1787–1795. doi: 10.1096/fasebj.13.13.1787. [DOI] [PubMed] [Google Scholar]
  97. Haroon Z. A., Lai T. S., Hettasch J. M., Lindberg R. A., Dewhirst M. W., Greenberg C. S. Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth. Lab Invest. 1999 Dec;79(12):1679–1686. [PubMed] [Google Scholar]
  98. Hettasch J. M., Bandarenko N., Burchette J. L., Lai T. S., Marks J. R., Haroon Z. A., Peters K., Dewhirst M. W., Iglehart J. D., Greenberg C. S. Tissue transglutaminase expression in human breast cancer. Lab Invest. 1996 Nov;75(5):637–645. [PubMed] [Google Scholar]
  99. Hettasch J. M., Greenberg C. S. Analysis of the catalytic activity of human factor XIIIa by site-directed mutagenesis. J Biol Chem. 1994 Nov 11;269(45):28309–28313. [PubMed] [Google Scholar]
  100. Hwang K. C., Gray C. D., Sivasubramanian N., Im M. J. Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C. J Biol Chem. 1995 Nov 10;270(45):27058–27062. doi: 10.1074/jbc.270.45.27058. [DOI] [PubMed] [Google Scholar]
  101. Iismaa S. E., Wu M. J., Nanda N., Church W. B., Graham R. M. GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J Biol Chem. 2000 Jun 16;275(24):18259–18265. doi: 10.1074/jbc.M000583200. [DOI] [PubMed] [Google Scholar]
  102. Ikura K., Kita K., Fujita I., Hashimoto H., Kawabata N. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe. Arch Biochem Biophys. 1998 Aug 15;356(2):280–286. doi: 10.1006/abbi.1998.0775. [DOI] [PubMed] [Google Scholar]
  103. Im M. J., Russell M. A., Feng J. F. Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell Signal. 1997 Nov;9(7):477–482. doi: 10.1016/s0898-6568(97)00049-1. [DOI] [PubMed] [Google Scholar]
  104. Ishii I., Ui M. Possible involvement of GTP-binding proteins in 1 alpha,25-dihydroxyvitamin D3 induction of tissue transglutaminase in mouse peritoneal macrophages. Biochem Biophys Res Commun. 1994 Sep 30;203(3):1773–1780. doi: 10.1006/bbrc.1994.2392. [DOI] [PubMed] [Google Scholar]
  105. Jetten A. M., Kim J. S., Sacks P. G., Rearick J. I., Lotan D., Hong W. K., Lotan R. Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid. Int J Cancer. 1990 Jan 15;45(1):195–202. doi: 10.1002/ijc.2910450135. [DOI] [PubMed] [Google Scholar]
  106. Johnson G. V., Cox T. M., Lockhart J. P., Zinnerman M. D., Miller M. L., Powers R. E. Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 1997 Mar 21;751(2):323–329. doi: 10.1016/s0006-8993(96)01431-x. [DOI] [PubMed] [Google Scholar]
  107. Johnson K., Hashimoto S., Lotz M., Pritzker K., Terkeltaub R. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol. 2001 Jul;159(1):149–163. doi: 10.1016/S0002-9440(10)61682-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Johnson T. S., Griffin M., Thomas G. L., Skill J., Cox A., Yang B., Nicholas B., Birckbichler P. J., Muchaneta-Kubara C., Meguid El Nahas A. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest. 1997 Jun 15;99(12):2950–2960. doi: 10.1172/JCI119490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Johnson T. S., Knight C. R., el-Alaoui S., Mian S., Rees R. C., Gentile V., Davies P. J., Griffin M. Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene. 1994 Oct;9(10):2935–2942. [PubMed] [Google Scholar]
  110. Johnson T. S., Scholfield C. I., Parry J., Griffin M. Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas. Biochem J. 1998 Apr 1;331(Pt 1):105–112. doi: 10.1042/bj3310105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Johnson T. S., Skill N. J., El Nahas A. M., Oldroyd S. D., Thomas G. L., Douthwaite J. A., Haylor J. L., Griffin M. Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol. 1999 Oct;10(10):2146–2157. doi: 10.1681/ASN.V10102146. [DOI] [PubMed] [Google Scholar]
  112. Jones R. A., Nicholas B., Mian S., Davies P. J., Griffin M. Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci. 1997 Oct;110(Pt 19):2461–2472. doi: 10.1242/jcs.110.19.2461. [DOI] [PubMed] [Google Scholar]
  113. Jürgensen K., Aeschlimann D., Cavin V., Genge M., Hunziker E. B. A new biological glue for cartilage-cartilage interfaces: tissue transglutaminase. J Bone Joint Surg Am. 1997 Feb;79(2):185–193. doi: 10.2106/00004623-199702000-00004. [DOI] [PubMed] [Google Scholar]
  114. Kaartinen M. T., Pirhonen A., Linnala-Kankkunen A., Mäenpä P. H. Transglutaminase-catalyzed cross-linking of osteopontin is inhibited by osteocalcin. J Biol Chem. 1997 Sep 5;272(36):22736–22741. doi: 10.1074/jbc.272.36.22736. [DOI] [PubMed] [Google Scholar]
  115. Kaetsu H., Hashiguchi T., Foster D., Ichinose A. Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. J Biochem. 1996 May;119(5):961–969. doi: 10.1093/oxfordjournals.jbchem.a021336. [DOI] [PubMed] [Google Scholar]
  116. Kanaji T., Ozaki H., Takao T., Kawajiri H., Ide H., Motoki M., Shimonishi Y. Primary structure of microbial transglutaminase from Streptoverticillium sp. strain s-8112. J Biol Chem. 1993 Jun 5;268(16):11565–11572. [PubMed] [Google Scholar]
  117. Karpuj Marcela V., Becher Mark W., Springer Joe E., Chabas Dorothee, Youssef Sawsan, Pedotti Rosetta, Mitchell Dennis, Steinman Lawrence. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med. 2002 Feb;8(2):143–149. doi: 10.1038/nm0202-143. [DOI] [PubMed] [Google Scholar]
  118. Keaveny A. P., Offner G. D., Bootle E., Nunes D. P. No significant difference in antigenicity or tissue transglutaminase substrate specificity of Irish and US wheat gliadins. Dig Dis Sci. 2000 Apr;45(4):755–762. doi: 10.1023/a:1005404012558. [DOI] [PubMed] [Google Scholar]
  119. Kim Eldar, Bobkova Elena, Hegyi György, Muhlrad Andras, Reisler Emil. Actin cross-linking and inhibition of the actomyosin motor. Biochemistry. 2002 Jan 8;41(1):86–93. doi: 10.1021/bi0113824. [DOI] [PubMed] [Google Scholar]
  120. Kim H. C., Nemes Z., Idler W. W., Hyde C. C., Steinert P. M., Ahvazi B. Crystallization and preliminary X-ray analysis of human transglutaminase 3 from zymogen to active form. J Struct Biol. 2001 Jul;135(1):73–77. doi: 10.1006/jsbi.2001.4384. [DOI] [PubMed] [Google Scholar]
  121. Kim I. G., Gorman J. J., Park S. C., Chung S. I., Steinert P. M. The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse. J Biol Chem. 1993 Jun 15;268(17):12682–12690. [PubMed] [Google Scholar]
  122. Kim S. Y., Chung S. I., Steinert P. M. Highly active soluble processed forms of the transglutaminase 1 enzyme in epidermal keratinocytes. J Biol Chem. 1995 Jul 28;270(30):18026–18035. doi: 10.1074/jbc.270.30.18026. [DOI] [PubMed] [Google Scholar]
  123. Kleman J. P., Aeschlimann D., Paulsson M., van der Rest M. Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry. 1995 Oct 24;34(42):13768–13775. doi: 10.1021/bi00042a007. [DOI] [PubMed] [Google Scholar]
  124. Knight C. R., Rees R. C., Elliott B. M., Griffin M. The existence of an inactive form of transglutaminase within metastasising tumours. Biochim Biophys Acta. 1990 Jun 12;1053(1):13–20. doi: 10.1016/0167-4889(90)90019-a. [DOI] [PubMed] [Google Scholar]
  125. Knight C. R., Rees R. C., Griffin M. Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim Biophys Acta. 1991 Jun 5;1096(4):312–318. doi: 10.1016/0925-4439(91)90067-j. [DOI] [PubMed] [Google Scholar]
  126. Kojima S., Inui T., Muramatsu H., Suzuki Y., Kadomatsu K., Yoshizawa M., Hirose S., Kimura T., Sakakibara S., Muramatsu T. Dimerization of midkine by tissue transglutaminase and its functional implication. J Biol Chem. 1997 Apr 4;272(14):9410–9416. doi: 10.1074/jbc.272.14.9410. [DOI] [PubMed] [Google Scholar]
  127. Kojima S., Inui T., Muramatsu H., Suzuki Y., Kadomatsu K., Yoshizawa M., Hirose S., Kimura T., Sakakibara S., Muramatsu T. Dimerization of midkine by tissue transglutaminase and its functional implication. J Biol Chem. 1997 Apr 4;272(14):9410–9416. doi: 10.1074/jbc.272.14.9410. [DOI] [PubMed] [Google Scholar]
  128. Kojima S., Nara K., Rifkin D. B. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol. 1993 Apr;121(2):439–448. doi: 10.1083/jcb.121.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Kojima S., Nara K., Rifkin D. B. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol. 1993 Apr;121(2):439–448. doi: 10.1083/jcb.121.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Kuncio G. S., Tsyganskaya M., Zhu J., Liu S. L., Nagy L., Thomazy V., Davies P. J., Zern M. A. TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. Am J Physiol. 1998 Feb;274(2 Pt 1):G240–G245. doi: 10.1152/ajpgi.1998.274.2.G240. [DOI] [PubMed] [Google Scholar]
  131. Lai T. S., Bielawska A., Peoples K. A., Hannun Y. A., Greenberg C. S. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J Biol Chem. 1997 Jun 27;272(26):16295–16300. doi: 10.1074/jbc.272.26.16295. [DOI] [PubMed] [Google Scholar]
  132. Lai T. S., Hausladen A., Slaughter T. F., Eu J. P., Stamler J. S., Greenberg C. S. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry. 2001 Apr 24;40(16):4904–4910. doi: 10.1021/bi002321t. [DOI] [PubMed] [Google Scholar]
  133. Lai T. S., Slaughter T. F., Koropchak C. M., Haroon Z. A., Greenberg C. S. C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity. J Biol Chem. 1996 Dec 6;271(49):31191–31195. doi: 10.1074/jbc.271.49.31191. [DOI] [PubMed] [Google Scholar]
  134. Lajemi M., Demignot S., Borge L., Thenet-Gauci S., Adolphe M. The use of Fluoresceincadaverine for detecting amine acceptor protein substrates accessible to active transglutaminase in living cells. Histochem J. 1997 Aug;29(8):593–606. doi: 10.1023/a:1026484227851. [DOI] [PubMed] [Google Scholar]
  135. Lee J. H., Jang S. I., Yang J. M., Markova N. G., Steinert P. M. The proximal promoter of the human transglutaminase 3 gene. Stratified squamous epithelial-specific expression in cultured cells is mediated by binding of Sp1 and ets transcription factors to a proximal promoter element. J Biol Chem. 1996 Feb 23;271(8):4561–4568. [PubMed] [Google Scholar]
  136. Lee K. N., Birckbichler P. J., Patterson M. K., Jr GTP hydrolysis by guinea pig liver transglutaminase. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1370–1375. doi: 10.1016/0006-291x(89)90825-5. [DOI] [PubMed] [Google Scholar]
  137. Lee K. N., Maxwell M. D., Patterson M. K., Jr, Birckbichler P. J., Conway E. Identification of transglutaminase substrates in HT29 colon cancer cells: use of 5-(biotinamido)pentylamine as a transglutaminase-specific probe. Biochim Biophys Acta. 1992 Jul 22;1136(1):12–16. doi: 10.1016/0167-4889(92)90078-p. [DOI] [PubMed] [Google Scholar]
  138. Lentini A., Kleinman H. K., Mattioli P., Autuori-Pezzoli V., Nicolini L., Pietrini A., Abbruzzese A., Cardinali M., Beninati S. Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation. Melanoma Res. 1998 Apr;8(2):131–137. doi: 10.1097/00008390-199804000-00005. [DOI] [PubMed] [Google Scholar]
  139. Lesort M., Attanavanich K., Zhang J., Johnson G. V. Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem. 1998 May 15;273(20):11991–11994. doi: 10.1074/jbc.273.20.11991. [DOI] [PubMed] [Google Scholar]
  140. Lesort M., Tucholski J., Miller M. L., Johnson G. V. Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol. 2000 Aug;61(5):439–463. doi: 10.1016/s0301-0082(99)00052-0. [DOI] [PubMed] [Google Scholar]
  141. Leszczyniecka M., Roberts T., Dent P., Grant S., Fisher P. B. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther. 2001 May-Jun;90(2-3):105–156. doi: 10.1016/s0163-7258(01)00132-2. [DOI] [PubMed] [Google Scholar]
  142. Liu Shenping, Cerione Richard A., Clardy Jon. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci U S A. 2002 Feb 26;99(5):2743–2747. doi: 10.1073/pnas.042454899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Lorand L., Conrad S. M. Transglutaminases. Mol Cell Biochem. 1984;58(1-2):9–35. doi: 10.1007/BF00240602. [DOI] [PubMed] [Google Scholar]
  144. Lorand L., Parameswaran K. N., Velasco P. T. Sorting-out of acceptor-donor relationships in the transglutaminase-catalyzed cross-linking of crystallins by the enzyme-directed labeling of potential sites. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):82–83. doi: 10.1073/pnas.88.1.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Lu S., Davies P. J. Regulation of the expression of the tissue transglutaminase gene by DNA methylation. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4692–4697. doi: 10.1073/pnas.94.9.4692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Lu W., Strohecker A., Ou Jh J. H. Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase. J Biol Chem. 2001 Oct 17;276(51):47993–47999. doi: 10.1074/jbc.M109674200. [DOI] [PubMed] [Google Scholar]
  147. Makarova K. S., Aravind L., Koonin E. V. A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases. Protein Sci. 1999 Aug;8(8):1714–1719. doi: 10.1110/ps.8.8.1714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Mariani P., Carsughi F., Spinozzi F., Romanzetti S., Meier G., Casadio R., Bergamini C. M. Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data. Biophys J. 2000 Jun;78(6):3240–3251. doi: 10.1016/S0006-3495(00)76860-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Mariniello L., Esposito C., Di Pierro P., Cozzolino A., Pucci P., Porta R. Human-immunodeficiency-virus transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro. Eur J Biochem. 1993 Jul 1;215(1):99–104. doi: 10.1111/j.1432-1033.1993.tb18011.x. [DOI] [PubMed] [Google Scholar]
  150. Mariniello L., Esposito C., Gentile V., Porta R. Transglutaminase covalently incorporates amines into human immunodeficiency virus envelope glycoprotein gp120 in vitro. Int J Pept Protein Res. 1993 Aug;42(2):204–206. doi: 10.1111/j.1399-3011.1993.tb00497.x. [DOI] [PubMed] [Google Scholar]
  151. Martinet N., Beninati S., Nigra T. P., Folk J. E. N1N8-bis(gamma-glutamyl)spermidine cross-linking in epidermal-cell envelopes. Comparison of cross-link levels in normal and psoriatic cell envelopes. Biochem J. 1990 Oct 15;271(2):305–308. doi: 10.1042/bj2710305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Martinez J., Chalupowicz D. G., Roush R. K., Sheth A., Barsigian C. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry. 1994 Mar 8;33(9):2538–2545. doi: 10.1021/bi00175a024. [DOI] [PubMed] [Google Scholar]
  153. Martinez J., Rich E., Barsigian C. Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells. J Biol Chem. 1989 Dec 5;264(34):20502–20508. [PubMed] [Google Scholar]
  154. Marzari R., Sblattero D., Florian F., Tongiorgi E., Not T., Tommasini A., Ventura A., Bradbury A. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol. 2001 Mar 15;166(6):4170–4176. doi: 10.4049/jimmunol.166.6.4170. [DOI] [PubMed] [Google Scholar]
  155. Matsumura Y., Chanyongvorakul Y., Kumazawa Y., Ohtsuka T., Mori T. Enhanced susceptibility to transglutaminase reaction of alpha-lactalbumin in the molten globule state. Biochim Biophys Acta. 1996 Jan 4;1292(1):69–76. doi: 10.1016/0167-4838(95)00197-2. [DOI] [PubMed] [Google Scholar]
  156. Melino G., Annicchiarico-Petruzzelli M., Piredda L., Candi E., Gentile V., Davies P. J., Piacentini M. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol. 1994 Oct;14(10):6584–6596. doi: 10.1128/mcb.14.10.6584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Melino G., Thiele C. J., Knight R. A., Piacentini M. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol. 1997 Jan;31(1-2):65–83. doi: 10.1023/a:1005733430435. [DOI] [PubMed] [Google Scholar]
  158. Mirza A., Liu S. L., Frizell E., Zhu J., Maddukuri S., Martinez J., Davies P., Schwarting R., Norton P., Zern M. A. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol. 1997 Feb;272(2 Pt 1):G281–G288. doi: 10.1152/ajpgi.1997.272.2.G281. [DOI] [PubMed] [Google Scholar]
  159. Mitkevich O. V., Shainoff J. R., DiBello P. M., Yee V. C., Teller D. C., Smejkal G. B., Bishop P. D., Kolotushkina I. S., Fickenscher K., Samokhin G. P. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody. J Biol Chem. 1998 Jun 5;273(23):14387–14391. doi: 10.1074/jbc.273.23.14387. [DOI] [PubMed] [Google Scholar]
  160. Monsonego A., Friedmann I., Shani Y., Eisenstein M., Schwartz M. GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase. J Mol Biol. 1998 Oct 2;282(4):713–720. doi: 10.1006/jmbi.1998.2052. [DOI] [PubMed] [Google Scholar]
  161. Mosher D. F. Cross-linking of fibronectin to collagenous proteins. Mol Cell Biochem. 1984;58(1-2):63–68. doi: 10.1007/BF00240605. [DOI] [PubMed] [Google Scholar]
  162. Muesch A., Hartmann E., Rohde K., Rubartelli A., Sitia R., Rapoport T. A. A novel pathway for secretory proteins? Trends Biochem Sci. 1990 Mar;15(3):86–88. doi: 10.1016/0968-0004(90)90186-f. [DOI] [PubMed] [Google Scholar]
  163. Murthy S. N. Prasanna, Iismaa Siiri, Begg Gillian, Freymann Douglas M., Graham Robert M., Lorand Laszlo. Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity. Proc Natl Acad Sci U S A. 2002 Feb 26;99(5):2738–2742. doi: 10.1073/pnas.052715799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Murthy S. N., Wilson J., Zhang Y., Lorand L. Residue Gln-30 of human erythrocyte anion transporter is a prime site for reaction with intrinsic transglutaminase. J Biol Chem. 1994 Sep 9;269(36):22907–22911. [PubMed] [Google Scholar]
  165. Nadeau O. W., Traxler K. W., Carlson G. M. Zero-length crosslinking of the beta subunit of phosphorylase kinase to the N-terminal half of its regulatory alpha subunit. Biochem Biophys Res Commun. 1998 Oct 20;251(2):637–641. doi: 10.1006/bbrc.1998.9507. [DOI] [PubMed] [Google Scholar]
  166. Nagy L., Saydak M., Shipley N., Lu S., Basilion J. P., Yan Z. H., Syka P., Chandraratna R. A., Stein J. P., Heyman R. A. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J Biol Chem. 1996 Feb 23;271(8):4355–4365. doi: 10.1074/jbc.271.8.4355. [DOI] [PubMed] [Google Scholar]
  167. Nagy L., Thomazy V. A., Heyman R. A., Davies P. J. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ. 1998 Jan;5(1):11–19. doi: 10.1038/sj.cdd.4400337. [DOI] [PubMed] [Google Scholar]
  168. Nagy L., Thomázy V. A., Saydak M. M., Stein J. P., Davies P. J. The promoter of the mouse tissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linked expression. Cell Death Differ. 1997 Oct;4(7):534–547. doi: 10.1038/sj.cdd.4400290. [DOI] [PubMed] [Google Scholar]
  169. Nakaoka H., Perez D. M., Baek K. J., Das T., Husain A., Misono K., Im M. J., Graham R. M. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 1994 Jun 10;264(5165):1593–1596. doi: 10.1126/science.7911253. [DOI] [PubMed] [Google Scholar]
  170. Nanda N., Iismaa S. E., Owens W. A., Husain A., Mackay F., Graham R. M. Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem. 2001 Mar 26;276(23):20673–20678. doi: 10.1074/jbc.M010846200. [DOI] [PubMed] [Google Scholar]
  171. Nemes Z., Jr, Adány R., Balázs M., Boross P., Fésüs L. Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis. J Biol Chem. 1997 Aug 15;272(33):20577–20583. doi: 10.1074/jbc.272.33.20577. [DOI] [PubMed] [Google Scholar]
  172. Nemes Z., Jr, Friis R. R., Aeschlimann D., Saurer S., Paulsson M., Fésüs L. Expression and activation of tissue transglutaminase in apoptotic cells of involuting rodent mammary tissue. Eur J Cell Biol. 1996 Jun;70(2):125–133. [PubMed] [Google Scholar]
  173. Noguchi K., Ishikawa K., Yokoyama Ki, Ohtsuka T., Nio N., Suzuki E. Crystal structure of red sea bream transglutaminase. J Biol Chem. 2000 Nov 15;276(15):12055–12059. doi: 10.1074/jbc.M009862200. [DOI] [PubMed] [Google Scholar]
  174. Orru Stefania, Ruoppolo Margherita, Francese Simona, Vitagliano Luigi, Marino Gennaro, Esposito Carla. Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase. Protein Sci. 2002 Jan;11(1):137–146. doi: 10.1110/ps.17102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Ou H., Haendeler J., Aebly M. R., Kelly L. A., Cholewa B. C., Koike G., Kwitek-Black A., Jacob H. J., Berk B. C., Miano J. M. Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells. Circ Res. 2000 Nov 10;87(10):881–887. doi: 10.1161/01.res.87.10.881. [DOI] [PubMed] [Google Scholar]
  176. Owen R. A., Bungay P. J., Hussain M., Griffin M. Transglutaminase-catalysed cross-linking of proteins phosphorylated in the intact glucose-stimulated pancreatic beta-cell. Biochim Biophys Acta. 1988 Feb 22;968(2):220–230. doi: 10.1016/0167-4889(88)90011-0. [DOI] [PubMed] [Google Scholar]
  177. Pasternack R., Dorsch S., Otterbach J. T., Robenek I. R., Wolf S., Fuchsbauer H. L. Bacterial pro-transglutaminase from Streptoverticillium mobaraense--purification, characterisation and sequence of the zymogen. Eur J Biochem. 1998 Nov 1;257(3):570–576. doi: 10.1046/j.1432-1327.1998.2570570.x. [DOI] [PubMed] [Google Scholar]
  178. Pastor M. T., Diez A., Pérez-Payá E., Abad C. Addressing substrate glutamine requirements for tissue transglutaminase using substance P analogues. FEBS Lett. 1999 May 28;451(3):231–234. doi: 10.1016/s0014-5793(99)00572-4. [DOI] [PubMed] [Google Scholar]
  179. Pedersen L. C., Yee V. C., Bishop P. D., Le Trong I., Teller D. C., Stenkamp R. E. Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Protein Sci. 1994 Jul;3(7):1131–1135. doi: 10.1002/pro.5560030720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Peters L. L., Jindel H. K., Gwynn B., Korsgren C., John K. M., Lux S. E., Mohandas N., Cohen C. M., Cho M. R., Golan D. E. Mild spherocytosis and altered red cell ion transport in protein 4. 2-null mice. J Clin Invest. 1999 Jun;103(11):1527–1537. doi: 10.1172/JCI5766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Piacentini Mauro, Farrace Maria Grazia, Piredda Lucia, Matarrese Paola, Ciccosanti Fabiola, Falasca Laura, Rodolfo Carlo, Giammarioli Anna Maria, Verderio Elisabetta, Griffin Martin. Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J Neurochem. 2002 Jun;81(5):1061–1072. doi: 10.1046/j.1471-4159.2002.00898.x. [DOI] [PubMed] [Google Scholar]
  182. Piredda L., Farrace M. G., Lo Bello M., Malorni W., Melino G., Petruzzelli R., Piacentini M. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J. 1999 Feb;13(2):355–364. doi: 10.1096/fasebj.13.2.355. [DOI] [PubMed] [Google Scholar]
  183. Pisano J. J., Finlayson J. S., Peyton M. P. [Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine]. Science. 1968 May 24;160(3830):892–893. doi: 10.1126/science.160.3830.892. [DOI] [PubMed] [Google Scholar]
  184. Plenz A., Fritz P., König G., Laschner W., Saal J. G. Immunohistochemical detection of factor XIIIa and factor XIIIs in synovial membranes of patients with rheumatoid arthritis or osteoarthritis. Rheumatol Int. 1996;16(1):29–36. doi: 10.1007/BF01419952. [DOI] [PubMed] [Google Scholar]
  185. Polakowska R. R., Graf B. A., Falciano V., LaCelle P. Transcription regulatory elements of the first intron control human transglutaminase type I gene expression in epidermal keratinocytes. J Cell Biochem. 1999 Jun 1;73(3):355–369. [PubMed] [Google Scholar]
  186. Puszkin E. G., Raghuraman V. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard. J Biol Chem. 1985 Dec 15;260(29):16012–16020. [PubMed] [Google Scholar]
  187. Rasmussen L. K., Sørensen E. S., Petersen T. E., Gliemann J., Jensen P. H. Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor. FEBS Lett. 1994 Jan 31;338(2):161–166. doi: 10.1016/0014-5793(94)80356-0. [DOI] [PubMed] [Google Scholar]
  188. Richards R. J., Masek L. C., Brown R. F. Biochemical and cellular mechanisms of pulmonary fibrosis. Toxicol Pathol. 1991;19(4 Pt 1):526–539. doi: 10.1177/019262339101900418. [DOI] [PubMed] [Google Scholar]
  189. Rosenthal A. K., Gohr C. M., Henry L. A., Le M. Participation of transglutaminase in the activation of latent transforming growth factor beta1 in aging articular cartilage. Arthritis Rheum. 2000 Aug;43(8):1729–1733. doi: 10.1002/1529-0131(200008)43:8<1729::AID-ANR8>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  190. Rubartelli A., Bajetto A., Allavena G., Wollman E., Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem. 1992 Dec 5;267(34):24161–24164. [PubMed] [Google Scholar]
  191. Rubartelli A., Cozzolino F., Talio M., Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 1990 May;9(5):1503–1510. doi: 10.1002/j.1460-2075.1990.tb08268.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Sane D. C., Moser T. L., Pippen A. M., Parker C. J., Achyuthan K. E., Greenberg C. S. Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun. 1988 Nov 30;157(1):115–120. doi: 10.1016/s0006-291x(88)80020-2. [DOI] [PubMed] [Google Scholar]
  193. Sblattero Daniele, Florian Fiorella, Azzoni Elisabetta, Zyla Trevin, Park Min, Baldas Valentina, Not Tarcisio, Ventura Alessandro, Bradbury Andrew, Marzari Roberto. The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments. Eur J Biochem. 2002 Nov;269(21):5175–5181. doi: 10.1046/j.1432-1033.2002.03215.x. [DOI] [PubMed] [Google Scholar]
  194. Schmidt G., Selzer J., Lerm M., Aktories K. The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem. 1998 May 29;273(22):13669–13674. doi: 10.1074/jbc.273.22.13669. [DOI] [PubMed] [Google Scholar]
  195. Schuppan D., Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E. O. Identification of the autoantigen of celiac disease. Ann N Y Acad Sci. 1998 Nov 17;859:121–126. doi: 10.1111/j.1749-6632.1998.tb11116.x. [DOI] [PubMed] [Google Scholar]
  196. Schuppan D., Hahn E. G. IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening. Eur J Gastroenterol Hepatol. 2001 Jun;13(6):635–637. doi: 10.1097/00042737-200106000-00004. [DOI] [PubMed] [Google Scholar]
  197. Seissler J., Schott M., Boms S., Wohlrab U., Ostendorf B., Morgenthaler N. G., Scherbaum W. A. Autoantibodies to human tissue transgutaminase identify silent coeliac disease in Type I diabetes. Diabetologia. 1999 Dec;42(12):1440–1441. doi: 10.1007/s001250051317. [DOI] [PubMed] [Google Scholar]
  198. Seissler J., Wohlrab U., Wuensche C., Scherbaum W. A., Boehm B. O. Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminase. Clin Exp Immunol. 2001 Aug;125(2):216–221. doi: 10.1046/j.1365-2249.2001.01584.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Seitz J., Keppler C., Hüntemann S., Rausch U., Aumüller G. Purification and molecular characterization of a secretory transglutaminase from coagulating gland of the rat. Biochim Biophys Acta. 1991 Jun 24;1078(2):139–146. doi: 10.1016/0167-4838(91)99002-a. [DOI] [PubMed] [Google Scholar]
  200. Sener A., Dunlop M. E., Gomis R., Mathias P. C., Malaisse-Lagae F., Malaisse W. J. Role of transglutaminase in insulin release. Study with glycine and sarcosine methylesters. Endocrinology. 1985 Jul;117(1):237–242. doi: 10.1210/endo-117-1-237. [DOI] [PubMed] [Google Scholar]
  201. Shimada J., Suzuki Y., Kim S. J., Wang P. C., Matsumura M., Kojima S. Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif. Mol Endocrinol. 2001 Oct;15(10):1677–1692. doi: 10.1210/mend.15.10.0707. [DOI] [PubMed] [Google Scholar]
  202. Shimizu T., Takao T., Hozumi K., Nunomura K., Ohta S., Shimonishi Y., Ikegami S. Structure of a covalently cross-linked form of core histones present in the starfish sperm. Biochemistry. 1997 Oct 7;36(40):12071–12079. doi: 10.1021/bi970922n. [DOI] [PubMed] [Google Scholar]
  203. Signorini M., Bortolotti F., Poltronieri L., Bergamini C. M. Human erythrocyte transglutaminase: purification and preliminary characterisation. Biol Chem Hoppe Seyler. 1988 Apr;369(4):275–281. doi: 10.1515/bchm3.1988.369.1.275. [DOI] [PubMed] [Google Scholar]
  204. Signorini M., Caselli L., Lanzara V., Ferrari C., Melandri P., Bergamini C. M. Properties of particulate transglutaminase from Yoshida tumor cells. Biol Chem Hoppe Seyler. 1996 Mar;377(3):167–173. doi: 10.1515/bchm3.1996.377.3.167. [DOI] [PubMed] [Google Scholar]
  205. Singh R. N., Mehta K. Purification and characterization of a novel transglutaminase from filarial nematode Brugia malayi. Eur J Biochem. 1994 Oct 15;225(2):625–634. doi: 10.1111/j.1432-1033.1994.00625.x. [DOI] [PubMed] [Google Scholar]
  206. Singh U. S., Kunar M. T., Kao Y. L., Baker K. M. Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J. 2001 May 15;20(10):2413–2423. doi: 10.1093/emboj/20.10.2413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Small K., Feng J. F., Lorenz J., Donnelly E. T., Yu A., Im M. J., Dorn G. W., 2nd, Liggett S. B. Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J Biol Chem. 1999 Jul 23;274(30):21291–21296. doi: 10.1074/jbc.274.30.21291. [DOI] [PubMed] [Google Scholar]
  208. Smethurst P. A., Griffin M. Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. Biochem J. 1996 Feb 1;313(Pt 3):803–808. doi: 10.1042/bj3130803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Staab J. F., Bradway S. D., Fidel P. L., Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999 Mar 5;283(5407):1535–1538. doi: 10.1126/science.283.5407.1535. [DOI] [PubMed] [Google Scholar]
  210. Stambolic V., Mak T. W., Woodgett J. R. Modulation of cellular apoptotic potential: contributions to oncogenesis. Oncogene. 1999 Nov 1;18(45):6094–6103. doi: 10.1038/sj.onc.1203126. [DOI] [PubMed] [Google Scholar]
  211. Steinert P. M., Chung S. I., Kim S. Y. Inactive zymogen and highly active proteolytically processed membrane-bound forms of the transglutaminase 1 enzyme in human epidermal keratinocytes. Biochem Biophys Res Commun. 1996 Apr 5;221(1):101–106. doi: 10.1006/bbrc.1996.0552. [DOI] [PubMed] [Google Scholar]
  212. Szegezdi E., Szondy Z., Nagy L., Nemes Z., Friis R. R., Davies P. J., Fésüs L. Apoptosis-linked in vivo regulation of the tissue transglutaminase gene promoter. Cell Death Differ. 2000 Dec;7(12):1225–1233. doi: 10.1038/sj.cdd.4400751. [DOI] [PubMed] [Google Scholar]
  213. Tarantini F., LaVallee T., Jackson A., Gamble S., Mouta Carreira C., Garfinkel S., Burgess W. H., Maciag T. The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock. J Biol Chem. 1998 Aug 28;273(35):22209–22216. doi: 10.1074/jbc.273.35.22209. [DOI] [PubMed] [Google Scholar]
  214. Thomázy V., Fésüs L. Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res. 1989 Jan;255(1):215–224. doi: 10.1007/BF00229084. [DOI] [PubMed] [Google Scholar]
  215. Tsai Y. H., Lai W. F., Chen S. H., Johnson L. R. A novel calcium-independent enzyme capable of incorporating putrescine into proteins. Biochem Biophys Res Commun. 1998 Mar 6;244(1):161–166. doi: 10.1006/bbrc.1998.8234. [DOI] [PubMed] [Google Scholar]
  216. Tsai Y. H., Lai W. F., Wu Y. W., Johnson L. R. Two distinct classes of rat intestinal mucosal enzymes incorporating putrescine into protein. FEBS Lett. 1998 Sep 18;435(2-3):251–256. doi: 10.1016/s0014-5793(98)01062-x. [DOI] [PubMed] [Google Scholar]
  217. Tucholski J., Kuret J., Johnson G. V. Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. J Neurochem. 1999 Nov;73(5):1871–1880. [PubMed] [Google Scholar]
  218. Tyrrell D. J., Sale W. S., Slife C. W. Fibronectin is a component of the sodium dodecyl sulfate-insoluble transglutaminase substrate. J Biol Chem. 1988 Jun 15;263(17):8464–8469. [PubMed] [Google Scholar]
  219. Umar S., Malavasi F., Mehta K. Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties. J Biol Chem. 1996 Jul 5;271(27):15922–15927. doi: 10.1074/jbc.271.27.15922. [DOI] [PubMed] [Google Scholar]
  220. Upchurch H. F., Conway E., Patterson M. K., Jr, Birckbichler P. J., Maxwell M. D. Cellular transglutaminase has affinity for extracellular matrix. In Vitro Cell Dev Biol. 1987 Nov;23(11):795–800. doi: 10.1007/BF02623682. [DOI] [PubMed] [Google Scholar]
  221. Uray I. P., Davies P. J., Fésüs L. Pharmacological separation of the expression of tissue transglutaminase and apoptosis after chemotherapeutic treatment of HepG2 cells. Mol Pharmacol. 2001 Jun;59(6):1388–1394. doi: 10.1124/mol.59.6.1388. [DOI] [PubMed] [Google Scholar]
  222. Velasco P. T., Murthy P., Goll D. E., Lorand L. Cross-linking and proteolysis in Ca2(+)-treated lens homogenates. Biochim Biophys Acta. 1990 Sep 3;1040(2):187–191. doi: 10.1016/0167-4838(90)90074-p. [DOI] [PubMed] [Google Scholar]
  223. Verderio E., Gaudry C., Gross S., Smith C., Downes S., Griffin M. Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1. J Histochem Cytochem. 1999 Nov;47(11):1417–1432. doi: 10.1177/002215549904701108. [DOI] [PubMed] [Google Scholar]
  224. Verderio E., Nicholas B., Gross S., Griffin M. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res. 1998 Feb 25;239(1):119–138. doi: 10.1006/excr.1997.3874. [DOI] [PubMed] [Google Scholar]
  225. Villalta Danilo, Bizzaro Nicola, Tonutti Elio, Tozzoli Renato. IgG anti-transglutaminase autoantibodies in systemic lupus erythematosus and Sjögren syndrome. Clin Chem. 2002 Jul;48(7):1133–1133. [PubMed] [Google Scholar]
  226. Weiss M. S., Metzner H. J., Hilgenfeld R. Two non-proline cis peptide bonds may be important for factor XIII function. FEBS Lett. 1998 Feb 27;423(3):291–296. doi: 10.1016/s0014-5793(98)00098-2. [DOI] [PubMed] [Google Scholar]
  227. Weiss M. S., Metzner H. J., Hilgenfeld R. Two non-proline cis peptide bonds may be important for factor XIII function. FEBS Lett. 1998 Feb 27;423(3):291–296. doi: 10.1016/s0014-5793(98)00098-2. [DOI] [PubMed] [Google Scholar]
  228. Yan Z. H., Noonan S., Nagy L., Davies P. J., Stein J. P. Retinoic acid induction of the tissue transglutaminase promoter is mediated by a novel response element. Mol Cell Endocrinol. 1996 Jul 1;120(2):203–212. doi: 10.1016/0303-7207(96)03826-9. [DOI] [PubMed] [Google Scholar]
  229. Yasueda H., Kumazawa Y., Motoki M. Purification and characterization of a tissue-type transglutaminase from red sea bream (Pagrus major). Biosci Biotechnol Biochem. 1994 Nov;58(11):2041–2045. doi: 10.1271/bbb.58.2041. [DOI] [PubMed] [Google Scholar]
  230. Yee V. C., Pedersen L. C., Le Trong I., Bishop P. D., Stenkamp R. E., Teller D. C. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7296–7300. doi: 10.1073/pnas.91.15.7296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Zauli D., Grassi A., Granito A., Foderaro S., De Franceschi L., Ballardini G., Bianchi F. B., Volta U. Prevalence of silent coeliac disease in atopics. Dig Liver Dis. 2000 Dec;32(9):775–779. doi: 10.1016/s1590-8658(00)80354-0. [DOI] [PubMed] [Google Scholar]
  232. Zhang J., Guttmann R. P., Johnson G. V. Tissue transglutaminase is an in situ substrate of calpain: regulation of activity. J Neurochem. 1998 Jul;71(1):240–247. doi: 10.1046/j.1471-4159.1998.71010240.x. [DOI] [PubMed] [Google Scholar]
  233. Zhang J., Lesort M., Guttmann R. P., Johnson G. V. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J Biol Chem. 1998 Jan 23;273(4):2288–2295. doi: 10.1074/jbc.273.4.2288. [DOI] [PubMed] [Google Scholar]
  234. Zhang J., Masui Y. Role of amphibian egg transglutaminase in the development of secondary cytostatic factor in vitro. Mol Reprod Dev. 1997 Jul;47(3):302–311. doi: 10.1002/(SICI)1098-2795(199707)47:3<302::AID-MRD9>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  235. Zhang L. X., Mills K. J., Dawson M. I., Collins S. J., Jetten A. M. Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J Biol Chem. 1995 Mar 17;270(11):6022–6029. doi: 10.1074/jbc.270.11.6022. [DOI] [PubMed] [Google Scholar]
  236. Zirvi K. A., Keogh J. P., Slomiany A., Slomiany B. L. Effects of exogenous transglutaminase on spreading of human colorectal carcinoma cells. Cancer Biochem Biophys. 1993 Sep;13(4):283–294. [PubMed] [Google Scholar]
  237. van Groningen J. J., Klink S. L., Bloemers H. P., Swart G. W. Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines. Int J Cancer. 1995 Jan 27;60(3):383–387. doi: 10.1002/ijc.2910600319. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES